VKTX
Viking Therapeutics, Inc.
Stock
$29.94−0.57 (−1.87%)Close Oct 2, 2026
- Cash and short-term investments, 2025
- $706M
- YoY, 2025
- −21.8%
- 5-year CAGR
- +23.2%
- 10-year CAGR
- +47.9%
Cash and short-term investments
Cash and short-term investments by fiscal year
| Period | Cash | YoY |
|---|---|---|
| 2025 | $706M | −21.8% |
| 2024 | $903M | +149.3% |
| 2023 | $362M | +132.9% |
| 2022 | $155M | −23.1% |
| 2021 | $202M | −18.6% |
| 2020 | $248M | −9.9% |
| 2019 | $276M | −8.6% |
| 2018 | $302M | +1,365.5% |
| 2017 | $21M | +56.5% |
| 2016 | $13M | −6.8% |
| 2015 | $14M | +1,766.0% |
| 2014 | $756K | — |